Co-abuse of amphetamine and alcohol harms kidney and liver.
Abuse
Alcohol
Amphetamine
Body mass
Kidney
Liver
Mental health
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
08 10 2024
08 10 2024
Historique:
received:
28
07
2024
accepted:
26
09
2024
medline:
9
10
2024
pubmed:
9
10
2024
entrez:
8
10
2024
Statut:
epublish
Résumé
The prevalence of alcohol use disorder was found 75% higher among amphetamine dependent patients. Alcohol and amphetamine alone have nephrotoxicity and hepatoxicity. But, the degree of risk with coabuse of alcohol and amphetamine is unknown. The objective of this study was to assess toxic effects of amphetamine-alcohol co-abuse on the liver and kidney. he present study was a cross-sectional study conducted et al. Amal Hospital for Mental Health, Qassim region, KSA and include one hundred participants. Seventy-five participants were patients hospitalized for the treatment of abuse, and twenty-five participants, were healthy voluntaries, have no history of abuse. An experienced psychiatrist conducted patient interviews and assessed the patients using the DSM-5 criteria. The data from healthy participants were considered as a control. The abuse group was paired with the control group by age and lifestyle. Participants were split into: Group I: Control group (n = 25); Group II: Amphetamine (AMP) abuser group (n = 25); Group III: Alcohol abuser group (n = 25) and Group IV: Combined drug abuser group (AMP and alcohol) (n = 25). The socio-demographic data was collected. Complete medical examination, Body Mass Index and samples of blood and urine were collected from all participants for analytical tests; determination of alcohol and AMP levels, kidney functions and liver functions. The mean BMI values in groups II, III, and IV showed no significant change from the control group. The serum level of albumin and alkaline phosphatase showed significant decrease in all abuser groups. While, alanine transaminase (ALT), Aspartate transaminase (AST) and osteopontin levels showed significant increase in all abuser groups. Fasting blood sugar values showed significant increase in alcohol abusers. On the other hand, it revealed no significant change in AMP and combined groups. The mean values of urea showed no significant change in AMP and alcohol abusers and significant increase in combined drug abuser group. The serum creatinine and all abuser groups showed significant increase in Cystatin C. The alteration in the most of studied biochemical parameters were more than two folds in combined group compared with that of AMP or alcohol groups. Study reveals synergistic liver and kidney toxicity. Amphetamine-alcohol co-abuse significantly heightens kidney and liver toxicity.
Identifiants
pubmed: 39379507
doi: 10.1038/s41598-024-74459-5
pii: 10.1038/s41598-024-74459-5
doi:
Substances chimiques
Amphetamine
CK833KGX7E
Ethanol
3K9958V90M
Cystatin C
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
23400Informations de copyright
© 2024. The Author(s).
Références
Stinson, F. S. et al. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend.80, 105–116 (2005).
pubmed: 16157233
doi: 10.1016/j.drugalcdep.2005.03.009
Halkitis, P. N., Green, K. A. & Mourgues, P. Longitudinal investigation of methamphetamine use among gay and bisexual men in New York City: Findings from Project BUMPS. J. Urban Health82, i18–i25 (2005).
pubmed: 15738324
pmcid: 3456170
doi: 10.1093/jurban/jti020
Attafi, I. M. et al. Analysis of fatalities involving amphetamine in Jazan, Saudi Arabia. Forensic Sci. Int. Rep.4, 100237 (2021).
doi: 10.1016/j.fsir.2021.100237
Peteria, P. Liver abnormalities in drug and substance abusers. Best Pract. Res. Clin. Gastroenterol.27(4), 577–596 (2013).
doi: 10.1016/j.bpg.2013.08.001
Ashok, K. Alcohol interaction with methamphetamine, opioids, nicotine, and γ-hydroxybutyric acid. Biomedicines7(1), 7–16 (2019).
Furr, C. D., Delva, J. & Anthony, J. C. The suspected association between methamphetamine (‘ice’) smoking and frequent episodes of alcohol intoxication: Data from the 1993 National Household Survey on Drug Abuse. Drug Alcohol Depend.59, 89–93 (2000).
pubmed: 10706978
doi: 10.1016/S0376-8716(99)00078-2
Shimosato, K. Urinary excretion of p-hydroxylated methamphetamine metabolites in man. II. Effect of alcohol intake on methamphetamine metabolism. Pharmacol. Biochem. Behav.29, 733 (1988).
pubmed: 3413199
doi: 10.1016/0091-3057(88)90195-5
Li, B., Wang, Y., Zhang, Y. & Liu, M. Effects of ethanol on the toxicokinetics of methamphetamine in rabbits. Iran. J. Pharm. Res.13, 329–336 (2014).
pubmed: 24734088
pmcid: 3985250
Kirkpatrick, G., Gunderson, W., Levin, R., Foltin, W. & Hart, L. Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humans. Psychopharmacology19, 191–204 (2019).
Narayan, A. J., Aitken, B., Downey, L. A. & Hayley, A. C. The effects of amphetamines alone and in combination with alcohol on functional neurocognition: A systematic review. Neurosci. Biobehav. Rev.131, 865–881 (2021).
pubmed: 34626687
doi: 10.1016/j.neubiorev.2021.10.003
Vaghef, L., Babri, S. & Vahed, M. The effect of escalating dose, multiple binge methamphetamine regimen and alcohol combination on spatial memory and oxidative stress markers in rat brain. J. Alcohol Drug Depend.2, 2 (2014).
Chen, L. Prescriptions, nonmedical use, and emergency department visits involving prescription stimulants. J. Clin. Psychiatry77(3), 297–304 (2016).
doi: 10.4088/JCP.14m09291
Ibrahim, Y. & Hussain, S. M. Patterns and sociodemographic characteristics of substance abuse in Al Qassim, Saudi Arabia. Ann. Saudi Med.38(5), 319–325 (2018).
pubmed: 30284986
pmcid: 6180213
doi: 10.5144/0256-4947.2018.319
Jonathan, D. Methamphetamine poisoning. CALL US Off. Newsl. Calif. Poison Control Syst.66(2), 56–59 (2008).
Rehm, J. The risk associated with alcohol use and alcoholism. Alcohol Res. Health34(2), 135–143 (2011).
pubmed: 22330211
pmcid: 3307043
Osna, N. Alcoholic liver disease: Pathogenesis and current management. Alcohol Res.38(2), 147–161 (2017).
pubmed: 28988570
pmcid: 5513682
Zoltan, V. Alcohol misuse and kidney injury. Alcohol Res.38(2), 283–288 (2017).
El-Masry, T. A., Elahwel, A. M. & Emara, A. M. Study on treating ethanol-induced gastric lesions with omeprazole, Nigella sativa oil, or both. Toxicol. Environ. Chem.92, 1765–1782 (2010).
doi: 10.1080/02772241003730589
WHO. World Health Organization: dependence syndrome. (2018).
Althobaiti, Y. S. & Sari, Y. Alcohol interactions with psychostimulants: An overview of animal and human studies. J. Addict. Res. Ther.7(3), 281 (2016).
pubmed: 27478679
pmcid: 4966675
doi: 10.4172/2155-6105.1000281
Siwar, M. A. A. L. et al. Health status outcome among cannabis addicts after treatment of addiction. PLoS One18(11), e0290730 (2023).
pubmed: 38011195
pmcid: 10681311
doi: 10.1371/journal.pone.0290730
Al Garea, M. H., Alqasoumi, A. A., Alqahtani, S. A., Hadadi, A. H. & Emara, A. M. Vitamin C as a potential ameliorating agent against hepatotoxicity among alcoholic abusers. Eur. Rev. Med. Pharmacol. Sci.27(8), 3322–3335 (2023).
pubmed: 37140282
Zhang, M. et al. The levels of triglyceride and total cholesterol in methamphetamine dependence. Medicine96, 663–671 (2010).
Gullberg, R. Determining The Air/Water partition coefficient to employ when calibrating forensic breath alcohol test instruments. Can. Soc. For. Sci. J.38(4), 205–212 (2005).
Bowers, L. D. & Wong, E. T. Kinetic serum creatinine assays. II. A critical evaluation and review. Clin. Chem.26, 555–561 (1980).
pubmed: 7020989
doi: 10.1093/clinchem/26.5.555
Huang, X. J. et al. Aspartate aminotransferase (AST/GOT) and alanine aminotransferase (ALT/GPT) detection techniques. Sensors (Basel)6(7), 756–782 (2006).
doi: 10.3390/s6070756
Gholami Bahnemiri, M. et al. Determination of serum alkaline phosphatase reference in healthy children aged 1–18 years. Caspian J. Intern. Med.13(4), 749–756 (2022).
pubmed: 36420337
pmcid: 9659844
Morales, O. et al. Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis. Hepatology58(5), 1742–1756 (2013).
doi: 10.1002/hep.26521
El-Gharbawy, R. M., Emara, A. M. & Abu-Risha, S. E. Zinc oxide nanoparticles and a standard antidiabetic drug restore the function and structure of beta cells in Type-2 diabetes. Biomed. Pharmacother.84, 810–820 (2016).
pubmed: 27723572
doi: 10.1016/j.biopha.2016.09.068
Patton, C. J. & Crouch, S. Spectrophotometric and kinetics investigation of the Berthelot reaction for the determination of ammonia. Anal. Chem.49, 464–469 (1977).
doi: 10.1021/ac50011a034
Jiang, R., Xu, C., Zhou, X., Wang, T. & Yao, G. Detection of cystatin C biomarker for clinical measurement of renal disease by developed ELISA diagnostic kits. J. Transl. Med.12, 205 (2014).
pubmed: 25216761
pmcid: 4262383
doi: 10.1186/1479-5876-12-205
Hangu, G. Pathogenesis of alcoholic liver disease. Clin. Liver Dis.20(3), 445–456 (2016).
doi: 10.1016/j.cld.2016.02.004
Schwartz, M. & Reinus, F. Prevalence and natural history of alcoholic liver disease. Clin. Liver Dis.16, 59–66 (2012).
doi: 10.1016/j.cld.2012.08.001
Hijioka, T. & Kashiwagi, T. Binding cells of 125I-iodoamphetamine in rat liver. Ann. Nucl. Med.11, 27–32 (1997).
pubmed: 9095319
doi: 10.1007/BF03164754
Setshedi, M., Wands, R. & Monte, M. Acetaldehyde adducts in alcoholic liver disease. Oxid. Med. Cell Longev.3(3), 178–185 (2010).
pubmed: 20716942
pmcid: 2952076
doi: 10.4161/oxim.3.3.12288
Aldubayan, M. A., Ahmed, A. S., Emara, A. M., Ahmed, A. A. & Elgharabawy, R. M. Sinapic acid attenuates cardiovascular disorders in rats by modulating reactive oxygen species and angiotensin receptor expression. Oxid. Med. Cell Longev.2020, 1–14 (2020).
doi: 10.1155/2020/1436858
Jones, K. Mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications Aliment. Pharmacol. Ther.13, 129–133 (1999).
AlOtaibi, S. D., Ashraf, M., Emara, A. M. & Elsisi, H. A. Mechanisms of psychiatric disorders induced by amphetamines: A comprehensive review. Int. J. Sci. Res. Arch.11(1), 260–274 (2024).
doi: 10.30574/ijsra.2024.11.1.0007
Fidler, H., Dhillon, A., Gertner, D. & Burroughs, A. Chronic ecstasy (3,4±methylenedioxymethamphetamine) abuse. J. Hepatol.25, 563–566 (1996).
pubmed: 8912157
doi: 10.1016/S0168-8278(96)80217-0
Beata, L., Marcin, Z. & Damian, C. Evaluation of drug dependent persons health on the basis of routine laboratory test results. Alcohol. Drug Addict.5(3), 9–15 (2016).
Stewart, H., Comte, S., Bowen, E. & Anton, F. Liver disease and HPLC quantification of disialotrans-ferrin for heavy alcohol use: A case series. Alcohol Clin. Exp. Res.34(11), 1956–1960 (2010).
pubmed: 20659069
pmcid: 3115778
doi: 10.1111/j.1530-0277.2010.01285.x
Kraus, L., Sthus, S., Amundsen, J., Piontek, D. & Legleye, S. Changes in mortality due to major alcohol-related diseases. Addiction110(9), 1443–1452 (2015).
pubmed: 25988372
doi: 10.1111/add.12989
Giboney, T. Elevated liver transaminase levels in the asymptomatic patient. Am. Fam. Phys.71, 1105–1110 (2005).
Nabavizadeha, F., Mehrdad, R., Alireza, F., Maryam, D. & Maryam, B. Methylenedioxymethamphetamine-induced acute liver injury in the rat. Iran. J. Pharm. Res.19(1), 343–354 (2020).
Osaretin, A. & Chioma, L. Gender and alcohol consumption affect human serum enzymes, protein and bilirubin. Asian J. Biochem.2(4), 330–336 (2007).
Saquib, N., Rajab, S. J. & AlMazrou, A. Substance use disorders in Saudi Arabia. Subst Abuse Treat.2(4), 33–40 (2020).
Patouraux, S., Bonnafous, S., Saint, E., Rosenthal, A. & Gual, P. The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease. PLoS One7, 35–44 (2012).
doi: 10.1371/journal.pone.0035612
Mindikoglu, L., Dowling, C., Weir, R., Seliger, L. & Magder, S. Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis. Hepatology (Baltimore, Md)59(4), 1532–1542 (2014).
pubmed: 23744636
doi: 10.1002/hep.26556
Randers, E., Kristensen, H., Erlandsen, J. & Danielsen, H. Serum cystatin C as a marker of the renal function. Scand. J. Clin. Lab. Investig.58(7), 585–592 (1998).
doi: 10.1080/00365519850186210
Das, K., Varadhan, S., Dhanya, L., Mukherjee, S. & Vasudevan, M. Effects of chronic ethanol exposure on renal function tests and oxidative stress in kidney. Indian J. Clin. Biochem.23(4), 341–344 (2008).
pubmed: 23105783
pmcid: 3453133
doi: 10.1007/s12291-008-0075-6
Bora, F., Yılmaz, F. & Bora, T. Ecstasy (MDMA) and its effects on kidneys and their treatment. Iran. J. Basic Med. Sci.19(4), 11–51 (2016).
Elgharabawy, R. M. & Emara, A. M. The protective effect of Panax ginseng against chromium picolonate induced testicular changes. Afr. J. Pharm. Pharmacol.8, 346–355 (2014).
doi: 10.5897/AJPP2013.3822
Stewart, H. Acute renal failure after amphetamine presenting with loin pain. Br. J. Urol.81, 160–161 (1998).
pubmed: 9467496
doi: 10.1046/j.1464-410x.1998.00349.x
Muoz, P., Drobinska, A., Bianchi, L., Zger, C. & Pirovino, M. Acute giant cell hepatitis in young population. Praxis Bern J.93, 109–112 (2004).
Varga, Z. V., Matyas, C., Paloczi, J. & Pacher, P. Alcohol misuse and kidney injury: Epidemiological evidence and potential mechanisms. Alcohol Res.38(2), 283–288 (2017).
pubmed: 28988579
pmcid: 5513691